HOME > ARCHIVE

ARCHIVE

Korosho to Draft Guidelines for Physician-led Clinical Trials

July 22, 2002
Otsuka Transfers Contract Lab Test Business to BML

July 22, 2002
BUSINESS NEWS IN BRIEF

July 15, 2002
Bayer BP Reports Possibility of Removal of Pathogenic Human Prion Protein

July 15, 2002
AstraZeneca Decides to Provide Iressa before Listing

July 15, 2002
RELOCATION

July 15, 2002
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

July 15, 2002
Esmolol, Ferucarbotran Recommended for Approval

July 15, 2002
RESEARCH & DEVELOPMENT NEWS IN BRIEF

July 15, 2002
WEBSITE NEWS

July 15, 2002
Generics of 162 Active Ingredients Included in NHI Price List

July 15, 2002
Press Seminar

July 15, 2002
Healthcare Reform to Raise People's Burden by \1.5 Trillion: Korosho

July 15, 2002
Takeda, J&J to Promote Tylenol for Use on Empty Stomach

July 15, 2002
Outline for Intellectual Property Strategy Finalized

July 15, 2002
Asahi Beer Pham Merges Its Drug and Food Subsidiaries

July 15, 2002
REGULATORY NEWS IN BRIEF

July 15, 2002
OTC NEWS IN BRIEF

July 15, 2002
National Nagano Hospital to Encourage Use of Generics

July 15, 2002
RDKK Aims at Sales of \60 Bil., 15% Share in 2006

July 15, 2002

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Beyond Elevidys: Next-Generation DMD Therapies Advance through Multiple Approaches

By Shinya Sato

The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…